𝔖 Bobbio Scriptorium

✦ LIBER ✦

Comparative economic data regarding lipid-lowering drugs

✍ Scribed by J.Sanford Schwartz

Book ID: 117011504
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 137 KB
Volume: 137
Category: Article
ISSN: 1097-6744
DOI: 10.1016/s0002-8703(99)70440-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipid-lowering drugs, cost-effectiveness

Lipid-lowering drugs, cost-effectiveness data, and the formulary system: A health systems perspective

✍ John M. Kessler 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 94 KB

The beneficial effects of lipid-lowering

The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: A comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia

✍ Ali Saklamaz; Abdurrahman Comlekci; Aysegul Temiz; Sezer Caliskan; Cengiz Ceylan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Measuring the cost-effectiveness of lipi

Measuring the cost-effectiveness of lipid-lowering drugs in the elderly:: the outcomes research and economic analysis components of the PROSPER trial

✍ Jerry Avorn; Josh Benner; Ian Ford; David A Ganz; Allan Gaw; Robert J Glynn; Jos 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Achievement of English National Service

Achievement of English National Service Framework lipid-lowering goals: pooled data from recent comparative treatment trials of statins at starting doses

✍ F. D. R. Hobbs; H. Southworth 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Combined intense lifestyle and pharmacol

Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease

✍ S. Sdringola; K. Nakagawa; U. Nakagawa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Combined intense lifestyle and pharmacol

Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease

✍ Stefano Sdringola; Keiichi Nakagawa; Yuko Nakagawa; S.Wamique Yusuf; Fernando Bo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 279 KB